Japanese Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Otsuka Holdings

Market Cap: JP¥4.2t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Carna Biosciences

Market Cap: JP¥4.3b

A clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan.

Ribomic

Market Cap: JP¥4.2b

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan.

Takara Bio

Market Cap: JP¥112.9b

Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.

CellSource

Market Cap: JP¥11.4b

Engages in the regenerative medicine-related businesses in Japan.

TMS

Market Cap: JP¥7.1b

Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.

Kissei Pharmaceutical

Market Cap: JP¥184.4b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Kidswell Bio

Market Cap: JP¥12.9b

Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.

Kringle Pharma

Market Cap: JP¥3.3b

Engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines.

Daiichi Sankyo Company

Market Cap: JP¥6.3t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

CanBas

Market Cap: JP¥22.8b

A clinical stage biopharmaceutical company, develops therapeutics for cancer patients.

Chugai Pharmaceutical

Market Cap: JP¥10.9t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Solasia Pharma K.K

Market Cap: JP¥9.5b

Engages in the development and marketing of oncology drugs in Japan and other Asian countries.

Kyowa Kirin

Market Cap: JP¥1.2t

Engages in the research, development, manufacturing, sells, and import/export of pharmaceuticals products worldwide.

Chordia Therapeutics

Market Cap: JP¥9.6b

A biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan.

Santen Pharmaceutical

Market Cap: JP¥536.5b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Noile-Immune Biotech

Market Cap: JP¥8.0b

Researches and develops CAR-T cells for cancer immunotherapies.

Veritas In Silico

Market Cap: JP¥4.6b

Engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA.

Nippon Shinyaku

Market Cap: JP¥223.0b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Precision System Science

Market Cap: JP¥5.7b

Develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products.

FunPep

Market Cap: JP¥4.3b

Engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides.

ReproCELL

Market Cap: JP¥18.9b

Provides stem cell research and drug discovery services in Japan.

Tsumura

Market Cap: JP¥274.6b

Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.

Shionogi

Market Cap: JP¥2.2t

Researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices.

WDB coco

Market Cap: JP¥6.5b

Provides contract services to pharmaceutical companies in Japan.

Immuno-Biological Laboratories

Market Cap: JP¥4.4b

Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.

Modalis Therapeutics

Market Cap: JP¥6.2b

Engages in the research and development of therapeutics to treat patients with serious genetic disorders.

Perseus Proteomics

Market Cap: JP¥4.9b

A drug discovery biotech venture company, develops antibody drugs against cancer and other diseases in Japan.

OncoTherapy Science

Market Cap: JP¥8.2b

Engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan.

Renascience

Market Cap: JP¥20.7b

Engages in the development and commercialization of pharmaceuticals and medical devices in Japan.

Heartseed

Market Cap: JP¥72.6b

Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.

StemRIM

Market Cap: JP¥18.6b

A biotechnology company, develops regeneration medicines for the treatment of intractable diseases.

Mochida Pharmaceutical

Market Cap: JP¥115.4b

Manufactures and sells pharmaceuticals and healthcare products in Japan.

Cuorips

Market Cap: JP¥58.4b

Engages in the research, development, manufacture, commercialization, and sale of iPS cell-derived cardiomyocyte sheets.

Stella Pharma

Market Cap: JP¥12.2b

Engages in the research, development, manufacturing, and distribution of pharmaceuticals.

Kaken Pharmaceutical

Market Cap: JP¥144.8b

Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.